Vera Therapeutics, Inc. (VERA) is a clinical-stage biotechnology company focused on developing transformative therapies for patients with serious immunological diseases. Their mission is to address unmet medical needs by creating innovative treatments targeting immune system pathways. Vera’s expertise lies in identifying and advancing therapies that have the potential to significantly improve patient outcomes in conditions […]
Read MoreBuy Price: $21.00 or better Sell Price: TradersPro Sell Signal INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient’s innate immune system to treat cancer Alzheimer’s disease, and non-alcoholic steatohepatitis. The company intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include […]
Read MoreEver since coronavirus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. As of this writing, vaccinations have steadily […]
Read MoreIt has been interesting to see how market commentary seems to have shifted as much as possible away from COVID-related news since the beginning of the year. In one sense, I think that could be a good thing, since there are a lot of issues, economic, political, and otherwise that are worthy of attention. This […]
Read MoreBuy Price: $80.00 or better Sell Price: TradersPro Sell Signal Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; […]
Read More